Penn Medicine Provider
Neurology
Lauren Elman, MD
4.9
(358)
Accepting new patients
Sees patients age 18 and up
Penn Neurology Pennsylvania Hospital
View 2 additional locations

About me

  • Director, Muscular Dystrophy Association Clinic
  • Director, Penn Comprehensive ALS Center
  • Professor of Neurology at the Hospital of the University of Pennsylvania and the Pennsylvania Hospital

Education and training

  • Medical School: Cornell University
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

359 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
i'm very comfortable asking questions
March 2025
5.0
5.0
dr elman is wonderful!
March 2025
5.0
5.0
she had good als knowledge
March 2025
5.0
5.0
took the time, was very clear what i have and what i need to do . amazing doctor

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Elman is a Penn Medicine physician.

Qualifications and experience

My research

Morganroth J, Bardakjian TM, Dratch L, Quinn CC, Elman LB Enhancing Clinical Infrastructure for the Delivery of Intrathecal and Genetic Therapies: A Qalsody (Tofersen) Model for Patients With SOD1-ALS , Neurol Clin Pract: 2024


Rhodes E, Alfa S, Jin HA, Massimo L, Elman L, Amado D, Baer M, Quinn C, McMillan CT Cognitive reserve in ALS: the role of occupational skills and requirements , Amyotroph Lateral Scler Frontotemporal Degener: 2024


Quinn C, Baer M, Amado DA, Kelley M, Elman L A single ALS center experience with clinical use of sodium phenylbutyrate-taurursodiol , Muscle Nerve: 2024


Robinson JL, Suh E, Xu Y, Hurtig HI, Elman L, McMillan CT, Irwin DJ, Porta S, Van Deerlin VM, Lee EB Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies , Acta Neuropathol, 147: 2024


Shellikeri S, Cho S, Ash S, Gonzalez-Recober C, Mcmillan CT, Elman L, Quinn C, Amado DA, Baer M, Irwin DJ, Massimo L, Olm CA, Liberman MY, Grossman M, Nevler N Digital markers of motor speech impairments in spontaneous speech of patients with ALS-FTD spectrum disorders , Amyotroph Lateral Scler Frontotemporal Degener: 2024


Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA. Disparities in Genetic Testing for Neurologic Disorders , Neurology: 2024


Dratch L, Bardakjian TM, Johnson K, Babaian N, Gonzalez-Alegre P, Elman L, Quinn C, Guo MH, Scherer SS, Amado DA The Importance of Offering Exome or Genome Sequencing in Adult Neuromuscular Clinics , Biology (Basel): 2024


Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon SC, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts , J Neurol: 2024


Shen T, Vogel JW, Duda J, Phillips JS, Cook PA, Gee J, Elman L, Quinn C, Amado DA, Baer M, Massimo L, Grossman M, Irwin DJ, McMillan CT Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum , Transl Neurodegener: 2023


Mitsumoto H, Jang G, Lee I, Simmons Z, Sherman AV, Heitzman D, Sorenson E, Cheung K, Andrews J, Harms M, Shneider NA, Santella R, Paganoni S, Ajroud-Driss S, Fernandes JAM, Burke KM, Gwathmey K, Habib AA, Maragakis NJ, Walk D, Fournier C, Heiman-Patterson T, Wymer J, Diaz F, Scelsa SN, Elman L, Genge A, Goutman SA, Hayat G, Jawdat O, Johnston WS, Joyce NC, Kasarskis EJ, Kisanuki YY, Lomen-Hoerth C, Pulley MT, Shah JS, Shoesmith C, Zinman L; PLS Natural History Study Group. Primary lateral sclerosis natural history study - planning, designing, and early enrollment , Amyotroph Lateral Scler Frontotemporal Degener: 2022